Manufacturer: Natco Pharma Ltd
Salt Composition : Lenalidomide(25mg)
This medication should not be taken if your body is hypersensitive to any substance present in it. Moreover, the medicine can harm a fetus, thus it should not be used by women who are expecting or those trying to conceive. Breastfeeding mothers should consult their medical providers before taking this medication.
The drug is meant to be taken orally, with or without food. Swallow the tablet as a whole do not chew, cut or break it.
This medicine is derived from thalidomide and is used for treating multiple myeloma and other cancers. It works in double mechanism mainly-in vitro and in vivo. In in vitro, tumour cells are disrupted from growing, angiogenesis is prevented and stimulates immunomodulation. In vivo, tumour cells are killed where bone marrow stromal cell support is inhibited and maintaining osteoclastogenic effects. Lenalidomide belongs to a class of immunomodulatory drugs.
Approximately 82 % of an oral dose is excreted as lenalidomide in urine within 24 h. Lenalidomide has a short half-life (3–4 h) and does not accumulate in plasma upon repeated dosing. Its pharmacokinetics are consistent across patient populations, regardless of the type of hematologic malignancy.
Headache
Nausea
Rash
Dizziness
Edema (Swelling)
Loss Of Appetite
Decreased White Blood Cell Count
Decreased Calcium Level
Muscle Weakness
Fatigue
Fever
Dry Skin
Weight Loss
Neuropathy
Constipation
Tremor
contraindicated in patients who have demonstrated hypersensitivity (e.g., angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis) to lenalidomide
This medicationis highly unsafe to use during pregnancy.
Interaction with alcohol is unknown. Please consult your doctor.
This medication is probably unsafe to use during breastfeeding. Please consult your doctor.
Lenalidomide is indicated for the treatment of adult patients with multiple myeloma (MM) in combination with dexamethasone. It is also indicated as maintenance therapy in multiple myeloma following autologous hematopoietic stem cell transplantation (auto-HSCT).
Drug-Drug Interactions: LENALIDOMIDE may interact with digitalis glycosides (digoxin), blood thinner (warfarin), and hormone (erythropoietin).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have anaemia, blood clots, infections, heart, kidney, or liver problems.
Drug-Drug Interactions Checker List:
DIGOXIN
WARFARIN
ERYTHROPOIETIN
Swallow the tablet as a whole do not chew, cut or break it.
Store below 30°C
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Seek emergency medical treatment or contact the doctor in case of an overdose.
The drug is meant to be taken orally, with or without food. Swallow the tablet as a whole do not chew, cut or break it.
Ques : What is Lenalid Mf 25Mg Capsule?
Ans : This medication is used to treat anaemia, which occurs in patients suffering from myelodysplastic syndrome (MDS).
Ques : How long do I need to use Lenalid Mf 25Mg Capsule before I see improvement in my condition?
Ans : This medication is to be taken till the time you see an improvement in your health conditions.
Ques : At what frequency do I need to use Lenalid Mf 25Mg Capsule?
Ans : This medication should be taken in the dosage as prescribed by the doctor.
Ques : Should I use Lenalid Mf 25Mg Capsule empty stomach, before food or after food?
Ans : This medication should be taken after food in a prescribed dosage.
Ques : What are the instructions for the storage and disposal of Lenalid Mf 25Mg Capsule?
Ans : This medication should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets.
